Subscribe to RSS
DOI: 10.1055/a-2765-5514
Key Causes and Temporal Window of Unplanned Readmissions Following Transsphenoidal Pituitary Surgery: A Systematic Review and Meta-analysis
Authors
Funding Information This work was supported by Shanghai Zhou Liangfu Medical Development Foundation (SM00036-2022-1).
Abstract
Objective
Unplanned readmission (UR) after transsphenoidal pituitary surgery poses a significant healthcare burden, but its exact incidence, causes, and risk factors remain unclear. This meta-analysis aims to estimate the 30-day UR rate, identify its main causes, and explore associated risk factors.
Methods
A systematic search of PubMed, Embase, Scopus, and Web of Science was conducted from inception to July 2025. Included studies reported 30-day UR rates and risk factors after transsphenoidal pituitary adenoma resection. Pooled incidence rates and odds ratios (ORs) with 95% confidence intervals (CIs) were derived using random-effects models. Heterogeneity was evaluated with I2 statistics, and study quality was assessed using the Newcastle-Ottawa scale.
Results
A total of 10 studies with 51,618 patients were included. The pooled 30-day UR rate was 9.68% (95% CI: 7.87–11.91). Hyponatremia (28.67%, 95% CI: 15.30–53.72) and cerebrospinal fluid leak (15.7%, 95% CI: 8.07–30.53) were the most common causes. Both all-cause and hyponatremia-related readmissions clustered early after surgery, with mean times of 9.96 days (95% CI: 6.51–13.42) and 8.05 days (95% CI: 5.86–10.25), respectively, suggesting a shared high-risk window around the first 2 weeks. No risk factor was reported in more than two studies, preventing meta-analysis of predictors.
Conclusion
This meta-analysis confirms a high 30-day UR rate (nearly 10%) after transsphenoidal pituitary surgery, primarily due to hyponatremia and CSF leak. The aligned timing of readmissions underscores a critical post-discharge period. These findings emphasize the need for structured follow-up and early intervention—especially extended electrolyte monitoring and complication-specific management—to effectively reduce readmission risk.
Keywords
pituitary adenoma - transsphenoidal surgery - unplanned readmission - meta-analysis - hyponatremia - cerebrospinal fluid leak - risk factorsData Availability Statement
The data that support the findings of this meta-analysis are available from the corresponding authors upon reasonable request. All data extracted from included studies are presented within the manuscript and its supplementary materials.
Informed Consent
This study is a meta-analysis based on previously published studies and does not involve direct contact with human or animal subjects.
‡ These authors contributed equally to this work.
Publication History
Received: 22 September 2025
Accepted: 04 December 2025
Accepted Manuscript online:
08 December 2025
Article published online:
18 December 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Potorac I, Petrossians P, Daly AF. et al. Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences. Endocr Relat Cancer 2015; 22 (02) 169-177
- 2 Møller MW, Andersen MS, Glintborg D. et al. Endoscopic vs. microscopic transsphenoidal pituitary surgery: a single centre study. Sci Rep 2020; 10 (01) 21942
- 3 Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med 2020; 382 (10) 937-950
- 4 Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu Rev Pathol 2009; 4: 97-126
- 5 Lake MG, Krook LS, Cruz SV. Pituitary adenomas: an overview. Am Fam Physician 2013; 88 (05) 319-327
- 6 Sheetrit E, Brief M, Elisha O. Predicting unplanned readmissions in the intensive care unit: a multimodality evaluation. Sci Rep 2023; 13 (01) 15426
- 7 Younus I, Gerges MM, Dobri GA, Ramakrishna R, Schwartz TH. Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases. J Neurosurg 2019; 133 (04) 1242-1247
- 8 Boling CC, Karnezis TT, Baker AB. et al. Multi-institutional study of risk factors for perioperative morbidity following transnasal endoscopic pituitary adenoma surgery. Int Forum Allergy Rhinol 2016; 6 (01) 101-107
- 9 Al-Qurayshi Z, Bennion DM, Greenlee JDW, Graham SM. Endoscopic pituitary surgery: national database review. Head Neck 2022; 44 (12) 2678-2685
- 10 Bur AM, Brant JA, Newman JG. et al. Incidence and risk factors for prolonged hospitalization and readmission after transsphenoidal pituitary surgery. Otolaryngol Head Neck Surg 2016; 155 (04) 688-694
- 11 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009; 3 (03) e123-e130
- 12 Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25 (09) 603-605
- 13 Wells GA, Shea B. O'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at:. https://onlinelibrary.wiley.com/doi/10.1002/jrsm.1077
- 14 Higgins JPT, Thomas J, Chandler J. et al. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3 ed.. Cochrane; 2022. Available at: https://www.cochrane.org/authors/handbooks-and-manuals/handbook
- 15 Tang A, Abdallah HM, Gardner PA. et al. Factors associated with a higher 30-day hospitalization period for pituitary adenoma patients: introducing a novel outcome metric. Neurosurgery 2025; 97 (05) 1141-1152
- 16 Kumar A, Rad MV, McGary AK, Castro JC, Cook CB. Factors associated with 30-day readmissions after transsphenoidal pituitary surgery. Endocr Pract 2025; 31 (01) 28-33
- 17 Ghiam MK, Chyou DE, Dable CL. et al. 30-day readmissions and coordination of care following endoscopic transsphenoidal pituitary surgery: experience with 409 patients. J Neurol Surg B Skull Base 2021; 83 (Suppl. 02) e410-e418
- 18 Hunsaker J, Khan M, Makarenko S, Evans J, Couldwell W, Karsy M. Prediction of readmission and complications after pituitary adenoma resection via the National Surgical Quality Improvement Program (NSQIP) database. Cureus 2021; 13 (05) e14809
- 19 Shaftel KA, Cole TS, Little AS. National trends in hospital readmission following transsphenoidal surgery for pituitary lesions. Pituitary 2020; 23 (02) 79-91
- 20 Cote DJ, Dasenbrock HH, Muskens IS. et al. Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 2017; 224 (05) 971-979
- 21 Hendricks BL, Shikary TA, Zimmer LA. Causes for 30-day readmission following transsphenoidal surgery. Otolaryngol Head Neck Surg 2016; 154 (02) 359-365
- 22 Bohl MA, Ahmad S, Jahnke H. et al. Delayed hyponatremia is the most common cause of 30-day unplanned readmission after transsphenoidal surgery for pituitary tumors. Neurosurgery 2016; 78 (01) 84-90
- 23 Schipmann S, Suero Molina E, Windheuser J. et al. The 30-day readmission rate in neurosurgery—a useful indicator for quality assessment?. Acta Neurochir (Wien) 2020; 162 (11) 2659-2669
- 24 Cusimano MD, Pshonyak I, Lee MY, Ilie G. Causes of 30-day readmission after neurosurgery of the spine. J Neurosurg Spine 2016; 24 (02) 281-290
- 25 Yu S, Taghvaei M, Collopy S. et al. Evaluation of early postoperative day 1 discharge after endoscopic endonasal pituitary adenoma resection. J Neurosurg 2021; 136 (05) 1337-1346
- 26 Sarkiss CA, Lee J, Papin JA. et al. Pilot study on early postoperative discharge in pituitary adenoma patients: effect of socioeconomic factors and benefit of specialized pituitary centers. J Neurol Surg B Skull Base 2015; 76 (04) 323-330
- 27 Guerra GA, Prasad A, Shah I. et al. Associations between tumor characteristics, postoperative complications, and early versus late discharge after endoscopic endonasal pituitary adenoma resection. Oper Neurosurg (Hagerstown) 2025; . Epub ahead of print
- 28 Hussain NS, Piper M, Ludlam WG, Ludlam WH, Fuller CJ, Mayberg MR. Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors. J Neurosurg 2013; 119 (06) 1453-1460
- 29 Tomita Y, Kurozumi K, Inagaki K. et al. Delayed postoperative hyponatremia after endoscopic transsphenoidal surgery for pituitary adenoma. Acta Neurochir (Wien) 2019; 161 (04) 707-715
- 30 Kunigelis KE, Arnone G, Chatain G. et al. Defining the timing and role of acute postoperative imaging in pituitary adenoma surgery: clinical study. Acta Neurochir (Wien) 2020; 162 (10) 2353-2360
- 31 Buttan A, Mamelak AN. Endocrine outcomes after pituitary surgery. Neurosurg Clin N Am 2019; 30 (04) 491-498
- 32 Klassen D, Mok S, Hwang JY. et al. Postoperative fluid restriction to prevent delayed hyponatremia after endoscopic transsphenoidal surgery. Neuro-oncol 2025; 27 (07) 1746-1757
- 33 Deaver KE, Catel CP, Lillehei KO, Wierman ME, Kerr JM. Strategies to reduce readmissions for hyponatremia after transsphenoidal surgery for pituitary adenomas. Endocrine 2018; 62 (02) 333-339
- 34 Winograd D, Staggers KA, Sebastian S, Takashima M, Yoshor D, Samson SL. An effective and practical fluid restriction protocol to decrease the risk of hyponatremia and readmissions after transsphenoidal surgery. Neurosurgery 2020; 87 (04) 761-769
- 35 Castle-Kirszbaum M, Goldschlager T, Shi MDY, Kam J, Fuller PJ. Postoperative fluid restriction to prevent hyponatremia after transsphenoidal pituitary surgery: an updated meta-analysis and critique. J Clin Neurosci 2022; 106: 180-184
- 36 Perez-Vega C, Tripathi S, Domingo RA. et al. Fluid restriction after transsphenoidal surgery for the prevention of delayed hyponatremia: a systematic review and meta-analysis. Endocr Pract 2021; 27 (09) 966-972
- 37 Ghorbani M, Keykhosravi E, Hasanpour M, Abbasian Ardakani A, Mohammad Hosseini E. The optimal time for postoperative magnetic resonance imaging of the sella in patients with pituitary adenoma. Basic Clin Neurosci 2024; 15 (05) 649-658
- 38 Kiliç T, Ekinci G, Seker A, Elmaci I, Erzen C, Pamir MN. Determining optimal MRI follow-up after transsphenoidal surgery for pituitary adenoma: scan at 24 hours postsurgery provides reliable information. Acta Neurochir (Wien) 2001; 143 (11) 1103-1126
